157 related articles for article (PubMed ID: 36428474)
21. Antagonizing bone morphogenetic protein 4 attenuates disease progression in a rat model of amyotrophic lateral sclerosis.
Shijo T; Warita H; Suzuki N; Ikeda K; Mitsuzawa S; Akiyama T; Ono H; Nishiyama A; Izumi R; Kitajima Y; Aoki M
Exp Neurol; 2018 Sep; 307():164-179. PubMed ID: 29932880
[TBL] [Abstract][Full Text] [Related]
22. Blood biomarkers and prognosis of amyotrophic lateral sclerosis.
Sun J; Carrero JJ; Zagai U; Evans M; Ingre C; Pawitan Y; Fang F
Eur J Neurol; 2020 Nov; 27(11):2125-2133. PubMed ID: 32557963
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor-β plasma levels and its role in amyotrophic lateral sclerosis.
Duque T; Gromicho M; Pronto-Laborinho AC; de Carvalho M
Med Hypotheses; 2020 Jun; 139():109632. PubMed ID: 32085981
[TBL] [Abstract][Full Text] [Related]
24. Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS).
Mandrioli J; Crippa V; Cereda C; Bonetto V; Zucchi E; Gessani A; Ceroni M; Chio A; D'Amico R; Monsurrò MR; Riva N; Sabatelli M; Silani V; Simone IL; Sorarù G; Provenzani A; D'Agostino VG; Carra S; Poletti A
BMJ Open; 2019 May; 9(5):e028486. PubMed ID: 31152038
[TBL] [Abstract][Full Text] [Related]
25. Expression of hepatocyte growth factor and c-Met in the anterior horn cells of the spinal cord in the patients with amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS and familial ALS with superoxide dismutase 1 gene mutation.
Kato S; Funakoshi H; Nakamura T; Kato M; Nakano I; Hirano A; Ohama E
Acta Neuropathol; 2003 Aug; 106(2):112-20. PubMed ID: 12707786
[TBL] [Abstract][Full Text] [Related]
26. Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients.
Müller Herde A; Schibli R; Weber M; Ametamey SM
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):407-420. PubMed ID: 30291374
[TBL] [Abstract][Full Text] [Related]
27. Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis.
Pasetto L; Pozzi S; Castelnovo M; Basso M; Estevez AG; Fumagalli S; De Simoni MG; Castellaneta V; Bigini P; Restelli E; Chiesa R; Trojsi F; Monsurrò MR; Callea L; Malešević M; Fischer G; Freschi M; Tortarolo M; Bendotti C; Bonetto V
J Neurosci; 2017 Feb; 37(6):1413-1427. PubMed ID: 28011744
[TBL] [Abstract][Full Text] [Related]
28. Aberrant Levels of Cystatin C in Amyotrophic Lateral Sclerosis: a Systematic Review and Meta Analysis.
Zhu Y; Yang M; Li F; Li M; Xu Z; Yang F; Liu Y; Chen W; Zhang Y; Xu R
Int J Biol Sci; 2018; 14(9):1041-1053. PubMed ID: 29989057
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.
Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P;
J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123
[TBL] [Abstract][Full Text] [Related]
30. ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression.
Quek H; Cuní-López C; Stewart R; Colletti T; Notaro A; Nguyen TH; Sun Y; Guo CC; Lupton MK; Roberts TL; Lim YC; Oikari LE; La Bella V; White AR
J Neuroinflammation; 2022 Feb; 19(1):58. PubMed ID: 35227277
[TBL] [Abstract][Full Text] [Related]
31. Lipopolysaccharide-binding protein, a surrogate marker of microbial translocation, is associated with physical function in healthy older adults.
Stehle JR; Leng X; Kitzman DW; Nicklas BJ; Kritchevsky SB; High KP
J Gerontol A Biol Sci Med Sci; 2012 Nov; 67(11):1212-8. PubMed ID: 22960476
[TBL] [Abstract][Full Text] [Related]
32. Exosomal TAR DNA-binding protein-43 and neurofilaments in plasma of amyotrophic lateral sclerosis patients: A longitudinal follow-up study.
Chen PC; Wu D; Hu CJ; Chen HY; Hsieh YC; Huang CC
J Neurol Sci; 2020 Nov; 418():117070. PubMed ID: 32836016
[TBL] [Abstract][Full Text] [Related]
33. Are Circulating Cytokines Reliable Biomarkers for Amyotrophic Lateral Sclerosis?
Moreno-Martinez L; Calvo AC; Muñoz MJ; Osta R
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195629
[TBL] [Abstract][Full Text] [Related]
34. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.
Tanaka M; Kikuchi H; Ishizu T; Minohara M; Osoegawa M; Motomura K; Tateishi T; Ohyagi Y; Kira J
J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis.
Gustafson MP; Staff NP; Bornschlegl S; Butler GW; Maas ML; Kazamel M; Zubair A; Gastineau DA; Windebank AJ; Dietz AB
PLoS One; 2017; 12(7):e0182002. PubMed ID: 28742871
[TBL] [Abstract][Full Text] [Related]
36. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
37. Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis.
Wilson ME; Boumaza I; Lacomis D; Bowser R
PLoS One; 2010 Dec; 5(12):e15133. PubMed ID: 21151566
[TBL] [Abstract][Full Text] [Related]
38. Reduced mitochondrial D-loop methylation levels in sporadic amyotrophic lateral sclerosis.
Stoccoro A; Smith AR; Mosca L; Marocchi A; Gerardi F; Lunetta C; Cereda C; Gagliardi S; Lunnon K; Migliore L; Coppedè F
Clin Epigenetics; 2020 Sep; 12(1):137. PubMed ID: 32917270
[TBL] [Abstract][Full Text] [Related]
39. Expression of different metallothionein messenger ribonucleic acids in motor cortex, spinal cord and liver from patients with amyotrophic lateral sclerosis.
Blaauwgeers HG; Anwar Chand M; van den Berg FM; Vianney de Jong JM; Troost D
J Neurol Sci; 1996 Oct; 142(1-2):39-44. PubMed ID: 8902718
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
;
Lancet Neurol; 2017 Jul; 16(7):505-512. PubMed ID: 28522181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
